OBJECTIVES: Most patients (75%) with Marfan syndrome present with aortic root dilatation that may require surgical intervention. However, associated cardiovascular disorders are not limited to the aortic root. These patients frequently require consecutive operations on the remaining thoracic aorta or the heart valves. Our intent was to characterize the spectrum of such procedures.
INTRODUCTION
Marfan syndrome is an autosomal dominant disease with a prevalence of 6.5 per 100 000 individuals [1] . The disease is due to mutation of the fibrillin-1-gene, leading to cardiovascular, ocular and skeletal manifestations [2] . Dilatation of aortic root occurs in 75% of all patients with Marfan syndrome, posing a distinct risk of rupture or dissection (7% per year) [3] . Life expectancy is therefore limited [4] . Various surgical techniques, including Bentall (valvereplacing root replacement) and David or Yacoub [valve-sparing root replacement (VSRR)] procedures, are known to effectively address such occurrences. In addition, the HAART annuloplasty ring (BioStable Science & Engineering, Austin, TX, USA) has been recently introduced for root restoration [5] .
Despite all measures done to prevent aortic root rupture or dissection, there is an inherent potential for other cardiovascular manifestations of Marfan syndrome to develop later. These subsequent developments, as well as early and late complications of aortic root surgery, typically necessitate a series of surgical interventions over time. Our aim was to determine the full spectrum of cardiac and thoracic aortic operations encountered in the long term after the initial aortic root surgery.
candidates for the study. Out of 73 patients, the diagnosis of a Marfan syndrome was assured in 68 patients on a molecular genetic basis. In 5 cases, the diagnosis was made according to the Ghent criteria without molecular genetic testing [6] .
Patient data were obtained from hospital charts and phone contact with patients or physicians. Follow-up was considered to be complete if survival and reoperations were known for the year 2016 or for at least 10 years after the initial operation. Follow-up data included times and descriptions of any reoperations and postoperative deaths as well as instances of endocarditis, cerebrovascular accidents or thromboembolic events. Minor procedures were defined as pacemaker implantation, re-exploration for bleeding/effusion and wound debridement. These were not included as events for 'freedom from subsequent operation' and the risk factor analysis. Two end-points were defined: (i) freedom from subsequent major operations involving thoracic aorta, aortic valve (AV) or atrioventricular valves and (ii) freedom from any related subsequent operation and death (combined end-point).
Univariable risk factor analysis was performed using the Cox regression analysis to calculate hazard ratios and the log-rank method to test for significance. Candidate factors were chosen according to their clinical relevance (age at operation <30 years, indication was dissection, implantation of a mechanical AV and concomitant mitral valve procedure). Analysis of risk factors for mortality was not performed due to the low number of events.
Statistical analysis
All data were analysed retrospectively. Normally distributed values were expressed as mean ± standard deviation, reporting non-normally distributed values as median (range). Z-scores were calculated using equations, as described by Campens et al. [7] . Freedom from subsequent operation and death (a combined end-point) was estimated by the Kaplan-Meier method to assess the proportion of patients experiencing uneventful courses. Differences between subgroups were calculated using the log-rank test, setting significance at P < 0.05. The R-environment version 3.1 (R Project for Statistical Computing, r-project.org) was engaged for all analyses.
RESULTS

Patient population and initial procedures
Patient characteristics at the time of aortic root surgery are presented in Table 1 . The indication for the initial aortic root surgery was dissection (Stanford Type A) in 16 patients and ascending aortic aneurysm in 57 others. Bentall procedures were performed in 33 patients (31 with mechanical valves) and using valvesparing techniques in the remaining 40 patients (David, 28;  Yacoub, 10; HAART annuloplasty, 2). In most patients presenting with dissections, a Bentall procedure was applied, with few exceptions (David, 2; Yacoub, 1). The preferred approach in elective surgeries had varied over the years, and until year 2000, the Bentall procedure prevailed. Between 2000 and 2004, the Yacoub procedure was used primarily. As of 2005, however, the David procedure was largely favoured, with only 2 HAART procedures recorded. The HAART procedure included a subaortic ring implantation and root replacement via the remodelling technique. Concomitant procedures are detailed in Table 2 .
Follow-up monitoring
After aortic root surgery, 30-day mortality was 0%. In our cohort, 64% of all patients had a regular follow-up at our hospital and 36% had a follow-up by their local physician. The median follow-up period was 8 years (0-28 years) and complete in 97% of the patients. Overall, 33 patients underwent 48 subsequent procedures during follow-up monitoring, and the median time from aortic root surgery to any further intervention being 3 years (5 days-14.4 years). The 48 operative procedures subsequently conducted involved the following: aorta, 23; AV, 11; mitral valve, 7 and combined procedures, 7 ( Fig. 1, Table 3 ).
Subsequent aortic valve procedures
Ten patients required 15 subsequent AV procedures. In the Bentall group, each of the 2 biological prosthesis recipients required later revisions due to valvular degeneration. Ultimately, 1 patient developed chronic heart failure, eventuating in cardiac transplantation. In the valve-sparing group, 8 patients were subjected to AV surgery due to severe AV insufficiency (David procedure: 4/28, 14%; Yacoub procedure: 4/10, 40%). This difference was not statistically significant (P = 0.2). In 1 patient with aortic regurgitation after an initial Yacoub procedure, valvular competency was restored through a David operation. Another patient initially treated by the David procedure later developed leaflet prolapse and aortic regurgitation. This was remedied using bovine pericardium for single-leaflet replacement. Mechanical valve replacements were performed in all the remaining instances of AV insufficiency. After the HAART procedures, patients were free of valvular insufficiency for a median of 2.0 years. One patient already subjected to valve replacement as a reoperation required yet another procedure for prosthetic endocarditis. During follow-up monitoring, patients with mechanical AVs experienced 5 episodes of major bleeding, 2 strokes and 2 bouts of endocarditis. One patient initially treated by VSRR presented with acute endocarditis.
Subsequent aortic procedures
Of the 57 patients initially presenting with aneurysms, 8 (14%) patients required one or more subsequent aortic procedures for the following reasons: acute or chronic dissection, 5; aneurysm of the untreated aorta, 2; and supravalvular stenosis (after the David procedure), 1. Of the 16 patients initially presenting with dissections, 7 (44%) patients required one or more subsequent aortic procedures due to persistent dissection. Patients initially presenting with aneurysms showed significantly greater freedom from subsequent aortic procedures than those presenting with dissections (P = 0.049).
Subsequent atrioventricular valvular procedures
Of the 14 patients who required mitral valve procedures prior to or in conjunction with root replacement, 1 (7%) patient required reoperation of the mitral valve (early valve failure, re-repaired on 8th postoperative day). In the remaining 59 patients, 8 (14%) patients underwent mitral valve repair (2 patients) or mechanical mitral valve replacement (6 patients) during the follow-up period. Seven of these patients had minimal (moderate in 1 instance) mitral valve regurgitation (MVR) at the time of aortic root replacement.
Minor procedures
A postoperative pacemaker implantation was necessary in 6 patients for complete AV block: 3 after a VSRR (David, n = 2; Yacoub, n = 1) and 3 after a Bentall operation (mechanical valve, n = 2; xenograft, n = 1).
One patient required rethoracotomy due to bleeding after a Yacoub procedure. Four patients required a pericardiotomy for pericardial effusion, 3 after a Bentall operation with a mechanical prosthesis and 1 after a Yacoub procedure.
Three patients required a sternal wound debridement due to a wound-healing deficit.
Mortality
Following the initial aortic root replacement, the 30-day mortality rate was 0%. Estimated survival rates after 1, 10 and 15 years were 100%, 85% and 82%, respectively (Fig. 2) . Nine late deaths occurred: 2 from strokes; 1 each from cerebral bleeding, respiratory failure, heart failure and pulmonary embolism and 3 others from unknown causes. Two deaths occurred within 30 days after subsequent procedures.
Freedom from subsequent operation and death (combined end-point) after 5, 10 and 15 years was 70%, 53% and 34%, respectively (Fig. 3) . Figure 4 depicts the univariable analysis of risk factors for reoperation. Dissection at the time of the initial operation merged as a significant risk factor for subsequent operations (P = 0.03). 
DISCUSSION
Until the 1970s, the reported life expectancy in patients with Marfan syndrome was as low as 32 years, given innate risks of aortic rupture and dissection [8] [9] [10] [11] . During the last several decades, however, more liberal and earlier decisions to opt for aortic root surgery have prolonged the lives of these patients [10] [11] [12] . Unfortunately, the cardiovascular manifestations of Marfan syndrome are multifaceted and progressive in nature. Early and late complications of aortic root surgery also contribute further to the burden of treatment. Patients may thus require operations with passage of time, aside from any initial procedures.
In the present study, the 1-year survival rate following aortic root surgery was excellent (100%). However, after 15 years, only 34% of patients were both alive and free from subsequent operative procedures. Patients free from mortality after 5, 10 and 15 years accounted for 97%, 90% and 85%, respectively. In another analysis, de Oliveira et al. [13] cited comparable 5-and 10-year survival rates of 89% and 81%, respectively. Similarly, previous studies have shown that depending on the initial pathology, 5-80% of patients with Marfan syndrome who undergo aortic root surgery will need additional operations [11, [14] [15] [16] [17] .
The Bentall procedure has typically represented the gold standard treatment in patients with Marfan syndrome who are candidates for aortic root surgery [18] , although the anticoagulation needed after mechanical valve implantation poses a risk of bleeding and thromboembolism in younger individuals. During the present investigation, major bleeding or stroke occurred in 5 recipients of mechanical valves, leading to fatal outcomes in 3 instances. However, valve-sparing procedures introduced by David and Yacoub [19, 20] have markedly improved the quality of life and long-term morbidity/mortality rates achieved. At the German Heart Center in Munich, the Yacoub procedure was instituted in 2000 and the David operation in 2005. Our results confirm previous studies showing that patients after the Yacoub operation have higher rates of AV insufficiency [21, 22] . In contrast to the Yacoub procedure, the aortic annulus is stabilized after the David procedure and thus protected from further dilatation [23] , After the David procedure, 86% of all patients showed a stable function of the AV. Previous studies showed that the benefits of a VSRR outweigh the disadvantage of a possible reoperation [24] , and our results confirm these findings.
The largest proportion of subsequent operations in our cohort was aortic procedures, most of which were undertaken in patients who presented with newly developed dissecting aneurysms or persistent dissections. Among patients with an aneurysm at the initial operation, 12% required an aortic arch replacement during the follow-up.
In contrast, 25% of patients with prior dissection required a secondary replacement of the aortic arch. This notably higher risk of late reintervention in patients with aortic dissections (versus aortic aneurysms) has been well described by others [14, 16, 24] . A replacement of the aortic arch concomitant to aortic root replacement seems to be desirable in patients with dissection. But the application of this more extensive operation may depend on intraoperative findings. According to our analysis, the chief indication for reoperation of the descending aorta is persistent dissection. The feasibility of treating the affected segments of aorta via thoracic endovascular aortic repair remains controversial [24] . To date, little is known of the long-term results in patients with Marfan syndrome. Case reports and small cohort studies (up to 12 patients) with no extended follow-up data are the only available publications at present [25] [26] [27] . Thoracic endovascular aortic repair was utilized in 8 patients of this cohort. During the followup period, endoleakage was detected, requiring thoracoabdominal aortic replacement in 1 patient, and a progressive thoraco-abdominal aneurysm required further stent implantation. Weighing these outcomes against the risk of thoracoabdominal aortic replacement, we do not see Marfan syndrome as a contraindication to descending aortic repair by thoracic endovascular aortic repair approach. Interestingly, the most common reason for subsequent operations in patients presenting initially with aneurysms was dissection of the native aorta.
Another frequent cardiac manifestation in patients with Marfan syndrome is mitral valve insufficiency, which may be attributed to the underlying microfibrillar tissue abnormality and progressive leaflet thickening [28] . In this study, 19% of patients had undergone mitral valve procedures prior to or in conjunction with aortic root replacements. Despite the lack of detectable MVR at the initial aortic root surgery, 14% developed severe MVR during follow-up monitoring, requiring subsequent interventions. In a study by Kunkala et al. [28] , mitral valve prolapse was documented in 69% of patients who presented for aortic root surgery. MVR was at least moderate in 9% of these patients, who then were surgically treated. Based on these findings and our analysis, we advise that moderate or severe degrees of MVR be addressed during initial operations while carefully observing the remaining patients.
Limitations
This investigation was a single-centre retrospective study. Patients selected for analysis were operated on within the past 28 years. During that time period, therapeutic regimens were likely to have changed, potentially influencing the results.
CONCLUSIONS
Once patients with Marfan syndrome undergo the initial aortic root replacement, subsequent operations are largely confined to the remaining aorta. To a lesser extent, aortic and mitral valves will require surgery as well. Currently, aortic root replacement and most subsequent procedures carry a low mortality risk. The need for subsequent procedures remains high even many years after the initial surgery. Therefore, lifelong patient monitoring for late-developing consequences of Marfan syndrome is imperative. We recommend a 1st computed tomography scan after Stanford Type A dissection 3 months after surgery, a 2nd scan 6 months after surgery, followed by scans once a year in patients without symptoms. Echocardiography is recommended 1 week and 6 months after surgery and during ongoing cardiac check-ups afterwards.
